Selenium – meaning in the prevention and therapy of cancer diseases

• Authors: Anita Molenda , Bożena Muszyńska

Title variants

PL

Selen – znaczenie w profilaktyce i terapii schorzeń nowotworowych

• Languages of publication: PL EN

Abstracts

EN

Selenium is a trace element supplied to the human body with food of plant and animal origin. It is a component of many enzymes with antioxidant activity, such as: glutathione peroxidase, seleniumprotein P, thioredoxin reductase and phospholipid hydroperoxide glutathione peroxidase. Being a component of enzymes, it protects cells against deformation and genetic damage thanks to the properties that inhibit the processes of lipid peroxidation, nucleic acids (DNA, RNA). The human body contains about 10-15 mg of selenium, 60% of which is found in erythrocytes, and 40% in blood. The problem of Poland and neighboring countries is the lack of this element in the soil, and therefore in the organisms of herbivorous farm animals. The lack of selenium in the meat of these animals causes significant deficiencies in the human body. In addition, due to the lack of this element in the soil, vegetables and preparations obtained from it do not constitute a suitable dietary source and intensify the problem of deficiency of this element in Europeans. Many studies indicate that both organic and inorganic selenium compounds reduce the progression of cancer by reducing the migration of cancer cells, inhibiting angiogenesis, and consequently reduce metastases.

Keywords

EN

Selol; anticancer activity; selenium compounds

Discipline

• MEDICINE: MEDICINE

• Publisher: ZOZ Ośrodek UMEA SHINODA-KURACEJO
• Journal: Medicina Internacia Revuo
• Year: 2017
• Volume: 28
• Issue: 109
• Pages: 272-279

Contributors

author

Anita Molenda

author

Bożena Muszyńska

• Department of Pharmaceutical Botany, Faculty of Pharmacy, Jagiellonian University, Medical College, Medyczna 9, 30-688 Kraków, Poland

References

• 1. Hatfield, D.L., Schweizer, U., Tsuji, P.A., Gladyshev, B.A.: Selenium, Its Molecular Biology and Role In Human Healh, 4 edition, 2016.
• 2. McKenzie, R., Rafferty, T., Beckett, G.; Immunol Today 1998, 19, 342-354.
• 3. Combs, G.F., Gray, J.W.; 1998, Pharmacol Ther. 79:179-92.
• 4. Ganther, H.E.; Carcinogenesis vol. 20 no. 9 pp. 1657-1666, 1999.
• 5. Lener, M., Jaworska-Bieniek, K., Muszyńska, M., Sukiennicki, G., Durda, K., Gromowski, T., Marciniak, W., Serrano-Fernández, P., Kładny, J., Wiechowska-Kozłowska, A., Grodzki, T., Jaworowska, E., Lubiński, J., Górecka-Szyld, B., Wilk, G., Huzarski, T., Byrski, T., Cybulski, C., Gronwald, J., Dębniak, T., Tołoczko-Grabarek, A., Morawski, A., Scott, R.J., Jakubowska, A., Lubiński, J.; opracowanie do celów edukacyjnych, http://www.read-gene.com/files/ckfinder/ file/Selen%20i%20rak.pdf.
• 6. Opoka, W., Muszyńska, B., Rutkowska, A., Schlegel-Zawadzka, M., Płonka, M.; Właściwości fizykochemiczne i biologiczne wybranych pierwiastków Wydawnictwo ZOZ Ośrodka UMEA Shinoda-Kuracejo, Kraków, 2015.
• 7. Putowski, M., Piróg, M., Padała, O., Piecewicz- Szczęsna, H., Zukow, W.; Journal of Education, Health and Sport. 2015; 5:73-84. ISSN 2391-8306.
• 8. Rayman, M.P.; Proc Nutr Soc 2005, 64: 527-542.
• 9. Raymann, M.P.; 2012a. Lancet. 379: 1256-68.
• 10. Raymann, M.P.; 2012b. International conference. Clinical genetics of hereditary cancers. Pp. 30- 31.08.2012, Szczecin, Poland.
• 11. Zwolak, I., Zaporowska, H.; 2012, Cell Biol Toxicol 28: 31-46
• 12. Reid, M., E., Duffield-Lillico, A., J., Garland, L., Turnbull, B.,W., Clark, L.,C., Marshall J.,R.; 2002, Cancer Epidemiol Biomark Prev. 11:1285–91.
• 13. Reid, M., E., Duffield-Lillico, A., J, Sunga, A., Fakih, M., Alberts, D.,S, Marshall, J.,R. ; 2006, Int J Cancer. 118: 1777-81.
• 14. Hatfield, D.L., Tsuji, P.A., Carlson, B.A., Gladyshev, V.N.; Trends In Biochemical Sciences, (2014) 39(3):112-20.
• 15. Rathner, Z.; 2014, JNCI, 919: 677.
• 16. Pechova, A., Pavlata, L., Illek, J.; 2005, Acta Veterinaria Brno 74, 483–490.
• 17. Muth, R., Muth, M.F.; 1958, Comments Postscript. Politics: Who Gets What, When, How. New York: Meridian-World, 181-211.
• 18. Mehdi, Y., Dufrasne, I. 2016), Molecules, 21, 545.
• 19. Galbraith, M.L., Vorachek, W.R., Estill, C.T., Whanger, P.D., Bobe, G., Davis, T.Z., Hall, J.A. 2016, Biol Trace Elem Res. 171(2):338-343.
• 20. Panev, A., Hauptmanová, K., Pavlata, L., Pechová, A., Filípek, J., Dvořák, R.; 2013, Czech J. Anim. Sci., 58, (1): 37–46.
• 21. Stewart, W.C., Bobe, G., Vorachek, W.R., Pirelli, G.J., Mosher, W.D., Nichols, T., Van Saun R.J., Forsberg N.E., Hall J.A.; (2012), Journal of Animal Science, 90, 577–584.
• 22. Pavlata, L., Misurova L., Pechova, A., Husakova, T., Dvorak, R.; 2012. Weterynaria Medicina 57, (5): 219–223.
• 23. Schrauzer, G., N., White, D.,A. and Schneider, C.,J. ;1977, Bioinorg Chem. 7: 23-31.
• 24. Duffield-Lillico, A.J., Reid, M.E, Turnbull, B.W, Combs, G.F, Jr, Slate, E.H, Fischbach, L.A, Marshall, J.R, Clark, L.C.; 2002, Cancer Epidemiol Biomarkers Prev. 11: 630.
• 25. Jaworska, K., Durda, K., Gupta, S., Muszyńska, M., Sukiennicki, G., Grodzki, T., Waloszczyk, P., Jaworowska, E., Lubiński, J., Kładny, J., Wilk, G., Gorecka, B., Sikorski, A., Gołąb, A., Wokołorczyk, D.,Cybulski, C., Tołoczko-Grabarek, A., Huzarski, T., Jakubowska A.; 2011,Wsp. Onkol. 15: 39-43.
• 26. Grodzki, T., Wojcik, J., Jakubowska, A., Wojcik, R., Muszyńska., M., Kubisa, B., Jaworska-Bieniek, K., Pierog, J., Gupta, S., Alchimowicz, J., Gromowski, T., Jankowski, H., Sukiennicki,G., Bielewicz, M., Lubiński, J. 2013; International Association for the Study of Lung Cancer (IASLC). 15th World Conference on Lung Cancer, October 27th – 30th, Sydney, Australia, In: Journal of Thoracic Oncology. 8: 328.
• 27. Lener, M.R, Gupta, S., Scott, R.J, Tootsi, M., Kulp, M., Tammesoo, M.L, Viitak, A., Metspalu, A., Serrano-Fernandez, P., Kładny, J., Jaworska-Bieniek, K., Durda, K., Muszyńska, M.,Sukiennicki, G., Jakubowska, A., Lubiński, J. 2013, BMC Cancer.13: 214.
• 28. Ou, Y., Jiang, B., Wang, X., Ma, W., Guo, J. 2012, Nutr Cancer; 64:1153-9.
• 29. Schrauzer, G., N.; 2000, J. Nutri. 130:1653-1656.
• 30. Adnan, A. i wsp.; 2010, Biol Trace Elem Res, 134:98–108.
• 31. Grober, U.: Leki i mikroskładniki odżywcze, MedPharm, Wrocław 2010.
• 32. Piasek, A., Bartoszek, A., Namieśnik, J.; 2009, Postępy Hig Med Dosw., 63: 142-158.
• 33. Zagrodzki, P.; 2004, Postępy Hig Med Dosw, 58: 140-149. 140.
• 34. Lubinski, J., Jaworska, K., Durda, K., Jakubowska, A., Huzarski T., Byrski, T., Stawicka, M., Gronwald, J., Górski, B., Wasowicz, W., Kilar, E., Szwiec, M., Surdyka, D., Marczyk, E., Sun, P., Narod, S.A.; Hered Cancer Clin Pract. 2011; 9 (Suppl 2): A5.
• 35. Puspitasari, I.M., Abdulah, R., Yamazaki, C., Kameo, S., Nakano, T., Koyama, H.; 2014, Radiat Oncol. 9: 125.
• 36. Bruns, F., Bruntzel, J., Mucke, R., Schonekaes,K., Kisters, K., Micke, O.;Med. Princ Pract., 2004, 13(4):185-190.
• 37. Weiss, J.F., Landauer, M.R.; Ann NY Acad Sci 2000, 899: 44-60.
• 38. Dennert, G., Horneber, M.; Cochrane Database Syst Rev 2006, 3: CD005037.
• 39. Franca, C.A., Nogueira, C.R., Ramalho, A., Carvalho, A.C., Vieira, S.L., Penna, A.B.; Ann Oncol 2011, 22: 1109-1112.
• 40. Elango, N., Samuel, S., Chinnakkannu P.; Clin Chim Acta 2006, 373: 92-98.
• 41. Flis-Borsuk, A., Śliwka, L., Suchocka Z., Borsuk, J., Fijałek, Z., Lubelska, K., Suchocki, P.; Biul. Wydz. Farm. WUM, 2016, 3, 17-24.
• 42. Dudkiewicz-Wilczyńska J., Książek I., Nowak, K., Suchocki, P., Flis, S., Kiljan, M., Anuszewska, E.; CHEMIK 2011, 65, 2.
• 43. Fitak, B., Grabowski, M., Suchocki, P.: Pol.PI. 176530 (CI. A6K31/095), 1999.

• Document Type: article